Open AccessCorrection to “A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy”
Author(s) -
Samuel G. Awuah,
YaoRong Zheng,
Peter M. Bruno,
Michael T. Hemann,
Stephen J. Lippard
Publication year - 2016
Publication title -
journal of the american chemical society
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 7.115
H-Index - 612
eISSN - 1520-5126
pISSN - 0002-7863
DOI - 10.1021/jacs.6b01316
Subject(s) - indoleamine 2,3 dioxygenase , chemistry , chemotherapy , drug , ovarian cancer , pharmacology , cancer research , cancer , medicine , biochemistry , tryptophan , amino acid
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom